Alzheimer’s disease seen through the eye using AI
A CUHK-led international team has successfully developed the world’s first AI model that can detect Alzheimer’s disease solely through fundus photographs.
The retina is an extension of the central nervous system; thus, the eye is a window that can show degenerative changes in the blood vessels and nerves of the brain. An international team led by CU Medicine has successfully developed the world’s first AI model that can detect Alzheimer’s disease solely through fundus photographs or images of the retina. The model is more than 80% accurate after validation.
Considering fundus photography is widely accessible, non-invasive and cost-effective, this novel AI model incorporated with fundus photography is expected to become an important tool for screening people at high risk of Alzheimer’s disease in the community. Details have been published in The Lancet Digital Health.
Deficiency to detect early Alzheimer’s disease
In Hong Kong, 1 in 10 people aged 70 or above suffers from dementia, with more than half of those cases attributed to Alzheimer’s disease. Alzheimer’s disease is associated with an excessive accumulation of abnormal amyloid plaque and neurofibrillary tangles in the brains, leading to the death of brain cells and resulting in progressive cognitive decline.
Dr. Lisa Au of the Division of Neurology said, ‘Memory complaints are common among middle-aged and elderly people, and often considered a sign of Alzheimer’s disease. It is sometimes difficult to make an accurate diagnosis of Alzheimer’s disease based on cognitive tests and structural brain imaging. However, methods to detect Alzheimer’s pathology, such as an amyloid-PET scan or testing of cerebrospinal fluid collected via lumber puncture, are invasive and less accessible.’
To address the current clinical gap, CU Medicine has led a number of medical centres and institutions from Singapore, the UK and the US to successfully develop an AI model using state-of-the-art technologies which can detect Alzheimer’s disease using fundus photographs alone.
Retina a window to study central nervous system disorders
Prof. Clement Tham, Chairman of the Department of Ophthalmology and Visual Sciences, explained, ‘The retina is an extension of the brain in terms of embryology, anatomy and physiology. In the entire central nervous system, only the blood vessels and nerves in the retina allow direct visualisation and analysis. Hence, it has long been considered a window to study disorders in the central nervous system. Through non-invasive fundus photography, we can detect a range of changes in the blood vessels and nerves of the retina that are associated with Alzheimer’s disease.’
The team developed and validated their AI model using nearly 13,000 fundus photographs from 648 Alzheimer’s disease patients and 3,240 cognitively normal subjects. Upon validation, the model showed 84% accuracy, 93% sensitivity and 82% specificity in detecting Alzheimer’s disease. In the multiethnic, multicountry datasets, the AI model achieved accuracies ranging from 80% to 92%.
The new AI model is accessible, non-invasive and accurate, showing its potential to become a diagnostic test in clinics and a screening tool for Alzheimer’s disease in community settings.
Non-invasive AI model more accessible and cost-effective
Prof. Vincent Mok, Director of the Therese Pei Fong Chow Research Centre for Prevention of Dementia, said, ‘In addition to its accessibility and non-invasiveness, the accuracy of the new AI model is comparable to imaging tests such as MRI. It shows potential to become not only a diagnostic test in clinics, but also a screening tool for Alzheimer’s disease in community settings. In the future, we hope to validate its efficacy in identifying high-risk cases of the disease hidden in the community so that various preventive treatments such as anti-amyloid drugs can be initiated early to slow down cognitive decline and brain damage.’
Dr. Carol Cheung of the Department of Ophthalmology and Visual Sciences, added, ‘In addition to applying novel AI technologies in the model, we also tested it in different scenarios. Notably, our AI model retained a robust ability to differentiate between subjects with and without Alzheimer’s disease, even in the presence of concomitant eye diseases like macular degeneration and glaucoma which are common in city-dwellers and the older population. This further supports the concept that our AI analysis of fundus photographs is an excellent tool for the detection of the memory-depriving Alzheimer’s disease.’
This article first appeared in the 7 December 2022 edition of CUHK In Focus.
Read more: